Céline Hummel
Chief Quality & Compliance Officer (CQO)
Strategic quality and compliance, with heart and mind - for trustworthy clinical research.
Céline Hummel has been helping to shape clinical research at the Swiss Cancer Institute (formerly SAKK) in Bern since 2016. As Chief Quality & Compliance Officer and member of the Executive Board, she has been driving the strategic development of the institute together with the team since October 2021. With 20 years of experience in clinical research, she is responsible for Quality Affairs, Regulatory Affairs, Pharmacovigilance, Legal Affairs and Facility Management as well as key topics such as data protection and risk management.
Her career began in 2006 at Clinipace (formerly PFC Pharma Focus AG), where she started as CRA/CPM and subsequently took on various management roles and led European teams.
Career
-
- Since 2021: Chief Quality & Compliance Officer (CQO)
- 2016 - 2021: Head of Monitoring and Clinical Project Management
-
- 2013 - 2015: Director Clinical Monitoring
- 2011 - 2013: National Manager Clinical Operations
- 2009 - 2012: Project Manager
- 2006 - 2011: Clinical Research Associate (CRA / sCRA)
Education
- 2009: Diploma of Advanced Studies (DAS) in Pharmaceutical Medicine, ECPM, University of Basel
- 2005: Master of Science in Movement Sciences, ETH Zurich
- 2002: Bachelor of Science in Biology, University Basel
Memberships
- Research Quality Association Ltd (RQA)
- Swiss Association of Pharmaceutical Professionals (SwAPP)
Languages
- German
- French
- English